Last updated Oct. 13, 2026
Ken Paxton FilesTexas’s attorney general, on the record
Claim check

Paxton says he’s protecting women from toxic products. He opened an investigation after winning the nomination, and nothing has come of it.

Our ratingMisleading

The feminine-care investigation was announced in July 2026 with no lawsuit or findings since, and his Tylenol suit rests on an autism link medical groups dispute.

Published Sept. 24, 20264 sources
The claim

Paxton claims his office is defending Texas women’s health against toxic chemicals in feminine-care products.

Source: Attorney General press release announcing investigations of feminine-care and lip-product brands, July 27, 2026 · Office of the Texas Attorney General

What the record shows

Paxton’s office announced investigations of Tampax, Kotex and other brands in July 2026, two months after he won the Republican Senate nomination. No lawsuit, finding or enforcement action has been reported. 01 02

His 2025 suit accusing the maker of Tylenol of misleading pregnant women rests on an autism link that medical groups dispute, and a judge rejected his request to block a $400 million shareholder payout. 03 04

The record behind this

  • Oct. 28, 2025
    Medical groups dispute the autism claim behind Paxton’s Tylenol suit

    The American College of Obstetricians and Gynecologists has said there is “no clear evidence” that prudent use of acetaminophen in pregnancy causes developmental problems.

  • Nov. 6, 2025
    Judge rejects Paxton’s bid to block a $400 million Kenvue payout

    A Panola County judge denied the state’s request to stop the dividend payments while the case is pending.

  • July 27, 2026
    Paxton’s women’s-products probe, announced after his nomination, has produced no lawsuit or findings

    KPRC reported that the announcement did not allege wrongdoing and that no enforcement action had been filed.

No public response found

No further public response found

We found no public statement from Paxton or his campaign on the status or results of the feminine-care investigation beyond the July 2026 announcement. 01

Last checked — Sept. 24, 2026

Sources

  1. 01Official statement
  2. 02Reporting
  3. 03Reporting
  4. 04Reporting